BRIEF published on 04/30/2024 at 19:59, 11 months 14 days ago GeNeuro presents its 2023 annual results and progresses in its research programs Financial Results Long Covid Medical Research Health GeNeuro SA
PRESS RELEASE published on 04/30/2024 at 19:54, 11 months 14 days ago Inside Information / News release on accounts, results GeNeuro reports 2023 full-year results and provides corporate update including completion of Phase 2 trial for temelimab against post-COVID neuropsychiatric syndromes. Financial visibility extended to Q3 2024 Full-year Results Phase 2 Trial GeNeuro Temelimab Post-COVID
Published on 04/14/2025 at 22:30, 29 minutes ago Bausch Health Announces Adoption of Shareholder Rights Plan
Published on 04/14/2025 at 22:15, 44 minutes ago Kingstone Announces Renewal Rights Transaction to Grow Homeowners Insurance Business in Downstate New York
Published on 04/14/2025 at 18:00, 4 hours 59 minutes ago IEH Corporation to Present at the Planet MicroCap Showcase
Published on 04/14/2025 at 15:20, 7 hours 39 minutes ago MicroVision Attains TISAX Assessment, An Important Achievement in Global Auto Industry
Published on 04/14/2025 at 15:00, 7 hours 59 minutes ago Wi2Wi Corporation Announces Full Year 2024 Financial Results
Published on 04/14/2025 at 20:10, 2 hours 49 minutes ago Morocco sets the stage for Africa’s digital future ahead of continental launchpad event for innovation, Artificial Intelligence (AI) and digital leadership in Marrakech
Published on 04/14/2025 at 19:02, 3 hours 56 minutes ago EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2025: EBIT below prior year – forecast confirmed due to good order development
Published on 04/14/2025 at 18:44, 4 hours 14 minutes ago Rack Centre’s LGS2 12MW Data Centre, gamechanger to revolutionise Nigeria’s Digital Landscape
Published on 04/14/2025 at 18:44, 4 hours 14 minutes ago fox e-mobility AG: Implementation of the Capital Resolutions of the Annual General Meeting -Financial Calendar
Published on 04/14/2025 at 18:04, 4 hours 54 minutes ago Disclosure of trading in own shares between April 7th and April 11th, 2025
Published on 04/14/2025 at 17:45, 5 hours 14 minutes ago PR - Decision of the Board of Directors on April 13, 2025
Published on 04/14/2025 at 17:35, 5 hours 24 minutes ago Disclosure of transactions in own shares from April 7 to April 11, 2025
Published on 04/14/2025 at 08:15, 14 hours 43 minutes ago Aéroports de Paris SA - Filing of the 2024 Universal Registration Document
